Furthermore, while CRP appeared to be comparable to IBI in AUC value for survival, a subanalysis limited to high‐risk stage II and stage III CRC patients indicated that it narrowly missed achieving statistical significance for DFS (data not shown). This evidence concerns the gene CRP and colorectal carcinoma.